
Africa - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Africa: Medicaments Containing Insulin Market 2023
Medicaments Containing Insulin Market Size in Africa
The African medicaments containing insulin market fell rapidly to $X in 2021, waning by -45.5% against the previous year. Over the period under review, consumption faced a abrupt downturn. Over the period under review, the market hit record highs at $X in 2013; however, from 2014 to 2021, consumption remained at a lower figure.
Medicaments Containing Insulin Production in Africa
In value terms, medicaments containing insulin production dropped slightly to $X in 2021 estimated in export price. The total production indicated perceptible growth from 2012 to 2021: its value increased at an average annual rate of +3.9% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +5.5% against 2019 indices. The pace of growth was the most pronounced in 2015 when the production volume increased by 30% against the previous year. Over the period under review, production hit record highs at $X in 2018; however, from 2019 to 2021, production remained at a lower figure.
Medicaments Containing Insulin Exports
Exports in Africa
After two years of decline, overseas shipments of medicaments containing insulin but not antibiotics increased by 45% to X tons in 2021. In general, exports, however, saw a drastic downturn. The pace of growth appeared the most rapid in 2015 when exports increased by 167% against the previous year. As a result, the exports reached the peak of X tons. From 2016 to 2021, the growth of the exports failed to regain momentum.
In value terms, medicaments containing insulin exports contracted to $X in 2021. Over the period under review, exports showed notable growth. The pace of growth appeared the most rapid in 2014 with an increase of 69% against the previous year. The level of export peaked at $X in 2020, and then dropped in the following year.
Exports by Country
In 2021, Botswana (X kg) and Swaziland (X kg) represented the key exporters of medicaments containing insulin but not antibiotics in Africa, together comprising 54% of total exports. South Africa (X kg) held the next position in the ranking, followed by Egypt (X kg), Kenya (X kg) and Tanzania (X kg). All these countries together took approx. 41% share of total exports. Tunisia (X kg) followed a long way behind the leaders.
From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Swaziland (with a CAGR of +125.7%), while the other leaders experienced more modest paces of growth.
In value terms, Botswana ($X) remains the largest medicaments containing insulin supplier in Africa, comprising 79% of total exports. The second position in the ranking was held by Swaziland ($X), with a 9.1% share of total exports. It was followed by Egypt, with a 7% share.
From 2012 to 2021, the average annual rate of growth in terms of value in Botswana totaled +70.2%. The remaining exporting countries recorded the following average annual rates of exports growth: Swaziland (+98.5% per year) and Egypt (-11.7% per year).
Export Prices by Country
The export price in Africa stood at $X per ton in 2021, with a decrease of -36% against the previous year. In general, the export price, however, enjoyed a resilient increase. The pace of growth appeared the most rapid in 2019 when the export price increased by 685%. Over the period under review, the export prices hit record highs at $X per ton in 2020, and then plummeted in the following year.
There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was Botswana ($X per ton), while South Africa ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Tunisia (+141.2%), while the other leaders experienced more modest paces of growth.
Medicaments Containing Insulin Imports
Imports in Africa
Medicaments containing insulin imports fell remarkably to X tons in 2021, reducing by -42.3% against 2020. Over the period under review, imports continue to indicate a abrupt contraction. The most prominent rate of growth was recorded in 2018 when imports increased by 179% against the previous year. The volume of import peaked at X tons in 2015; however, from 2016 to 2021, imports remained at a lower figure.
In value terms, medicaments containing insulin imports dropped markedly to $X in 2021. In general, imports recorded a abrupt setback. The most prominent rate of growth was recorded in 2018 with an increase of 130% against the previous year. The level of import peaked at $X in 2012; however, from 2013 to 2021, imports remained at a lower figure.
Imports by Country
Nigeria (X tons) and Ethiopia (X tons) represented roughly 60% of total imports in 2021. It was distantly followed by Tunisia (X tons), Sudan (X tons) and Ghana (X tons), together making up a 24% share of total imports. The following importers - Senegal (X tons) and Burundi (X tons) - together made up 6.9% of total imports.
From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Senegal (with a CAGR of +75.2%), while imports for the other leaders experienced more modest paces of growth.
In value terms, Nigeria ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Africa, comprising 58% of total imports. The second position in the ranking was held by Ethiopia ($X), with a 17% share of total imports. It was followed by Tunisia, with a 10% share.
In Nigeria, medicaments containing insulin imports increased at an average annual rate of +10.8% over the period from 2012-2021. The remaining importing countries recorded the following average annual rates of imports growth: Ethiopia (+32.4% per year) and Tunisia (-28.0% per year).
Import Prices by Country
The import price in Africa stood at $X per ton in 2021, falling by -6.6% against the previous year. Over the period under review, the import price continues to indicate a pronounced setback. The growth pace was the most rapid in 2016 an increase of 102%. Over the period under review, import prices hit record highs at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Nigeria ($X per ton), while Sudan ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Nigeria (+13.6%), while the other leaders experienced more modest paces of growth.
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2022 | 2012-2022 | 2023-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in Africa. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Making Data-Driven Decisions to Grow Your Business
A Quick Overview of Market Performance
Understanding the Current State of The Market and Its Prospects
Finding New Products to Diversify Your Business
Choosing the Best Countries to Establish Your Sustainable Supply Chain
Choosing the Best Countries to Boost Your Exports
The Latest Trends and Insights into The Industry
The Largest Importers on The Market and How They Succeed
The Largest Exporters on The Market and How They Succeed
The Largest Producers on The Market and Their Profiles
The Largest Markets And Their Profiles
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 22nd, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 8th, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, January 25th, 2022 @ 04:00 pm ET